Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
2123 studies found for:    diabetes | NIH
Show Display Options
RSS Create an RSS feed from your search for:
diabetes | NIH
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Active, not recruiting Look AHEAD: Action for Health in Diabetes
Conditions: Diabetes;   Myocardial Infarction;   Stroke;   Kidney Diseases;   Bone Diseases;   Dyslipidemia
Interventions: Behavioral: Lifestyle Intervention;   Behavioral: Diabetes Support and Education
2 Recruiting Pathway to Prevention Study
Condition: Diabetes Mellitus, Type 1
Intervention:
3 Completed
Has Results
Rituximab in New Onset Type 1 Diabetes
Condition: Type 1 Diabetes Mellitus
Interventions: Drug: Anti-CD20 (rituximab);   Drug: Placebo Comparator
4 Completed Islet Transplantation in Type 1 Diabetes
Condition: Type 1 Diabetes Mellitus
Interventions: Biological: Allogeneic Pancreatic Islet Cells;   Biological: Antithymocyte Globulin;   Drug: Sirolimus;   Drug: Tacrolimus;   Biological: Etanercept;   Procedure: Islet Transplantation;   Biological: Basiliximab
5 Completed Improving Metabolic Assessments in Type 1 Diabetes Mellitus Clinical Trials
Condition: Diabetes Mellitus, Type 1
Interventions: Procedure: Mixed Meal Tolerance Test;   Procedure: Glucagon Stimulation Test
6 Unknown  Parental Management of Young Children's Diabetes
Condition: Diabetes Mellitus, Type 1
Interventions: Behavioral: Parental Support;   Behavioral: Diabetes Education
7 Recruiting Teplizumab for Prevention of Type 1 Diabetes In Relatives "At-Risk"
Conditions: Autoantibody Positive;   Non-diabetic Relatives at Risk for Type 1 Diabetes;   High Risk;   Impaired Glucose Tolerance
Intervention: Drug: Teplizumab
8 Completed Evaluation of Diabetes Self-Management Consultant Care
Condition: Type 2 Diabetes Mellitus
Interventions: Behavioral: Diabetes Self-Management Consultant;   Behavioral: Enhanced Usual Care Control Group
9 Unknown  A Comprehensive Intervention for Diabetes and Comorbid Depression in Primary Care
Conditions: Type 2 Diabetes;   Major Depressive Disorder
Interventions: Behavioral: Diabetes and depression intervention;   Behavioral: Diabetes intervention
10 Completed Peritransplant Deoxyspergualin in Islet Transplantation in Type 1 Diabetes
Condition: Diabetes Mellitus, Type 1
Interventions: Biological: Allogeneic Pancreatic Islet Cells;   Drug: Deoxyspergualin;   Biological: Antithymocyte globulin;   Biological: Daclizumab or basiliximab;   Drug: Sirolimus;   Drug: Tacrolimus;   Biological: Etanercept
11 Active, not recruiting ATG-GCSF in New Onset Type 1 Diabetes
Condition: Diabetes Mellitus, Type 1
Interventions: Drug: Anti-Thymocyte Globulin (ATG);   Drug: Granulocyte colony stimulating factor (GCSF);   Drug: Placebo (for ATG);   Drug: Placebo (for GCSF)
12 Completed Family Management of Type 1 Diabetes in Children
Condition: Diabetes Mellitus, Type 1
Intervention: Behavioral: family diabetes management intervention
13 Unknown  Diabetes Prevention Program Outcomes Study
Condition: Diabetes Mellitus
Interventions: Behavioral: Group Lifestyle;   Drug: Metformin;   Behavioral: Boost Lifestyle
14 Active, not recruiting Reducing Stress in Adolescents and Young Adults With T1D to Improve Diabetes Care
Condition: Type 1 Diabetes
Interventions: Behavioral: Cognitive Behavioral Therapy;   Behavioral: Mindfulness Based Stress Reduction;   Behavioral: Diabetes Support and Education
15 Completed
Has Results
New Onset of Type 1 Diabetes Mycophenolate Mofetil-Daclizumab Clinical Trial
Condition: Diabetes Mellitus, Type 1
Interventions: Drug: Mycophenolate mofeteil (MMF);   Drug: Daclizumab (DZB);   Drug: Placebo control for Mycophenolate mofeteil (MMF);   Drug: Placebo control for Daclizumab (DZB)
16 Recruiting CTLA4-Ig (Abatacept)for Prevention of Abnormal Glucose Tolerance and Diabetes in Relatives At -Risk for Type 1
Conditions: Abnormal Glucose Tolerance;   Type 1 Diabetes
Interventions: Drug: CTLA4-Ig (Abatacept);   Drug: Placebo
17 Completed
Has Results
Intravenous CTLA4-lg Treatment in Recent Onset Type 1 Diabetes Mellitus
Condition: Type 1 Diabetes Mellitus
Interventions: Drug: CTLA-4 Ig;   Other: Placebo
18 Completed Vermont Diabetes Information System
Condition: Diabetes Mellitus
Intervention: Other: Information and decision support for providers and patients
19 Enrolling by invitation TODAY2 Phase 2 Follow-up
Condition: Type 2 Diabetes
Intervention: Other: TODAY cohort
20 Active, not recruiting Oral Insulin for Prevention of Diabetes in Relatives at Risk for Type 1 Diabetes Mellitus
Condition: Diabetes Mellitus, Type 1
Intervention: Drug: Oral Insulin

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.